Concepts (198)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Oils, Volatile | 7 | 2019 | 13 | 2.090 |
Why?
|
| Gas Chromatography-Mass Spectrometry | 10 | 2019 | 82 | 1.640 |
Why?
|
| Anti-Bacterial Agents | 4 | 2025 | 415 | 1.440 |
Why?
|
| Caenorhabditis elegans | 3 | 2017 | 78 | 1.340 |
Why?
|
| Azo Compounds | 2 | 2021 | 17 | 1.210 |
Why?
|
| Sulfonylurea Compounds | 2 | 2017 | 17 | 1.020 |
Why?
|
| Clothing | 2 | 2016 | 9 | 1.010 |
Why?
|
| Thiazolidinediones | 2 | 2017 | 49 | 0.990 |
Why?
|
| Metformin | 2 | 2017 | 74 | 0.960 |
Why?
|
| Thiazoles | 1 | 2025 | 76 | 0.910 |
Why?
|
| Fatty Acids | 2 | 2016 | 134 | 0.910 |
Why?
|
| Chromatography, High Pressure Liquid | 6 | 2017 | 458 | 0.880 |
Why?
|
| Fungi | 5 | 2011 | 103 | 0.880 |
Why?
|
| Drug Design | 1 | 2025 | 183 | 0.840 |
Why?
|
| Antifungal Agents | 4 | 2011 | 169 | 0.820 |
Why?
|
| Antioxidants | 3 | 2012 | 439 | 0.800 |
Why?
|
| Carcinogens | 2 | 2021 | 126 | 0.790 |
Why?
|
| Monoterpenes | 3 | 2019 | 10 | 0.770 |
Why?
|
| Environmental Exposure | 2 | 2017 | 247 | 0.730 |
Why?
|
| Antinematodal Agents | 2 | 2013 | 5 | 0.700 |
Why?
|
| Textiles | 2 | 2021 | 7 | 0.680 |
Why?
|
| Coloring Agents | 2 | 2021 | 56 | 0.670 |
Why?
|
| Food Contamination | 2 | 2015 | 55 | 0.670 |
Why?
|
| Gram-Negative Bacteria | 3 | 2011 | 27 | 0.660 |
Why?
|
| Gram-Positive Bacteria | 3 | 2025 | 18 | 0.610 |
Why?
|
| Mentha spicata | 1 | 2019 | 1 | 0.610 |
Why?
|
| Spices | 2 | 2015 | 9 | 0.580 |
Why?
|
| Quorum Sensing | 2 | 2008 | 14 | 0.550 |
Why?
|
| Plant Extracts | 3 | 2012 | 303 | 0.540 |
Why?
|
| Simvastatin | 1 | 2017 | 29 | 0.540 |
Why?
|
| Lighting | 1 | 2017 | 12 | 0.530 |
Why?
|
| Spectrophotometry, Ultraviolet | 1 | 2017 | 103 | 0.520 |
Why?
|
| Mutagens | 2 | 2015 | 76 | 0.510 |
Why?
|
| Glipizide | 1 | 2016 | 5 | 0.500 |
Why?
|
| Environmental Monitoring | 3 | 2016 | 226 | 0.500 |
Why?
|
| Carbamates | 1 | 2016 | 13 | 0.500 |
Why?
|
| Guanidines | 1 | 2016 | 18 | 0.500 |
Why?
|
| Amines | 1 | 2016 | 40 | 0.490 |
Why?
|
| Apiaceae | 1 | 2015 | 3 | 0.490 |
Why?
|
| Plant Oils | 2 | 2014 | 20 | 0.490 |
Why?
|
| Light | 1 | 2017 | 182 | 0.490 |
Why?
|
| Piperidines | 1 | 2016 | 80 | 0.480 |
Why?
|
| Terpenes | 2 | 2013 | 29 | 0.480 |
Why?
|
| Metals | 1 | 2016 | 113 | 0.480 |
Why?
|
| Triglycerides | 1 | 2015 | 146 | 0.460 |
Why?
|
| Models, Theoretical | 1 | 2017 | 230 | 0.460 |
Why?
|
| Foeniculum | 2 | 2014 | 2 | 0.460 |
Why?
|
| Fruit | 2 | 2015 | 178 | 0.450 |
Why?
|
| Tea | 1 | 2015 | 46 | 0.440 |
Why?
|
| Chromatography, Liquid | 1 | 2015 | 173 | 0.440 |
Why?
|
| Selenium | 1 | 2016 | 150 | 0.440 |
Why?
|
| Arsenic | 1 | 2016 | 151 | 0.440 |
Why?
|
| Hypoglycemic Agents | 1 | 2016 | 181 | 0.430 |
Why?
|
| Coffee | 1 | 2014 | 20 | 0.420 |
Why?
|
| Trace Elements | 2 | 2016 | 34 | 0.400 |
Why?
|
| Seeds | 2 | 2015 | 46 | 0.400 |
Why?
|
| Charcoal | 1 | 2013 | 6 | 0.400 |
Why?
|
| Smoke | 1 | 2013 | 41 | 0.390 |
Why?
|
| Microbial Sensitivity Tests | 3 | 2025 | 232 | 0.370 |
Why?
|
| Environmental Pollutants | 1 | 2014 | 198 | 0.350 |
Why?
|
| Rosa | 1 | 2011 | 2 | 0.350 |
Why?
|
| Structure-Activity Relationship | 3 | 2025 | 491 | 0.350 |
Why?
|
| Pesticide Residues | 1 | 2011 | 9 | 0.350 |
Why?
|
| Flowers | 1 | 2011 | 20 | 0.340 |
Why?
|
| Hair | 1 | 2011 | 38 | 0.340 |
Why?
|
| Hydrocarbons, Chlorinated | 1 | 2011 | 21 | 0.340 |
Why?
|
| Chromatography, Supercritical Fluid | 2 | 2014 | 3 | 0.340 |
Why?
|
| Food Analysis | 2 | 2015 | 34 | 0.340 |
Why?
|
| Molecular Structure | 3 | 2025 | 560 | 0.330 |
Why?
|
| Anti-Infective Agents | 1 | 2011 | 74 | 0.330 |
Why?
|
| Quantitative Structure-Activity Relationship | 2 | 2008 | 110 | 0.320 |
Why?
|
| Free Radical Scavengers | 1 | 2010 | 63 | 0.310 |
Why?
|
| Polyesters | 2 | 2021 | 26 | 0.300 |
Why?
|
| Biofilms | 2 | 2008 | 178 | 0.300 |
Why?
|
| Pest Control | 1 | 2008 | 4 | 0.300 |
Why?
|
| Nematoda | 1 | 2008 | 11 | 0.300 |
Why?
|
| Organic Chemicals | 1 | 2008 | 35 | 0.290 |
Why?
|
| Acyl-Butyrolactones | 1 | 2008 | 2 | 0.290 |
Why?
|
| Crops, Agricultural | 1 | 2008 | 36 | 0.290 |
Why?
|
| Fabaceae | 1 | 2008 | 29 | 0.290 |
Why?
|
| Water Supply | 1 | 2008 | 59 | 0.280 |
Why?
|
| Bacteria | 1 | 2011 | 285 | 0.270 |
Why?
|
| Water Microbiology | 1 | 2008 | 82 | 0.270 |
Why?
|
| Farnesol | 1 | 2007 | 4 | 0.270 |
Why?
|
| Metals, Heavy | 1 | 2008 | 69 | 0.270 |
Why?
|
| Humans | 16 | 2025 | 42163 | 0.260 |
Why?
|
| Antineoplastic Agents | 2 | 2025 | 979 | 0.250 |
Why?
|
| Artemisia | 1 | 2006 | 3 | 0.250 |
Why?
|
| Smoking | 1 | 2013 | 1019 | 0.240 |
Why?
|
| Coronary Sinus | 1 | 2025 | 2 | 0.240 |
Why?
|
| Glycoconjugates | 1 | 2025 | 6 | 0.240 |
Why?
|
| Angina Pectoris | 1 | 2025 | 20 | 0.240 |
Why?
|
| Neuralgia, Postherpetic | 1 | 2025 | 3 | 0.230 |
Why?
|
| Multiple Sclerosis, Relapsing-Remitting | 1 | 2025 | 2 | 0.230 |
Why?
|
| Nitro Compounds | 1 | 2025 | 34 | 0.230 |
Why?
|
| Anticonvulsants | 1 | 2025 | 39 | 0.230 |
Why?
|
| Benzimidazoles | 1 | 2025 | 41 | 0.230 |
Why?
|
| Essential Tremor | 1 | 2025 | 3 | 0.230 |
Why?
|
| Transcranial Magnetic Stimulation | 1 | 2025 | 14 | 0.230 |
Why?
|
| Atrazine | 1 | 2005 | 8 | 0.230 |
Why?
|
| Nitriles | 1 | 2025 | 78 | 0.230 |
Why?
|
| Pyridones | 1 | 2025 | 50 | 0.230 |
Why?
|
| Cerebellum | 1 | 2025 | 78 | 0.220 |
Why?
|
| Animals | 6 | 2025 | 16695 | 0.220 |
Why?
|
| Glycosides | 1 | 2024 | 22 | 0.220 |
Why?
|
| Triazoles | 1 | 2025 | 100 | 0.220 |
Why?
|
| Immunosuppressive Agents | 1 | 2025 | 94 | 0.220 |
Why?
|
| Herbicides | 1 | 2005 | 44 | 0.220 |
Why?
|
| Drug Screening Assays, Antitumor | 1 | 2024 | 147 | 0.210 |
Why?
|
| Protein Kinase Inhibitors | 1 | 2025 | 159 | 0.210 |
Why?
|
| Pilonidal Sinus | 1 | 2023 | 1 | 0.210 |
Why?
|
| Pyridines | 1 | 2024 | 134 | 0.210 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 1 | 2005 | 456 | 0.200 |
Why?
|
| Lipid Metabolism | 2 | 2016 | 140 | 0.200 |
Why?
|
| Computer Simulation | 1 | 2025 | 404 | 0.200 |
Why?
|
| Sepsis | 1 | 2023 | 90 | 0.190 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2025 | 1112 | 0.190 |
Why?
|
| Cell Proliferation | 2 | 2025 | 1420 | 0.180 |
Why?
|
| Biological Assay | 2 | 2013 | 63 | 0.170 |
Why?
|
| Treatment Outcome | 4 | 2025 | 1586 | 0.170 |
Why?
|
| Chromatography, Thin Layer | 2 | 2010 | 39 | 0.150 |
Why?
|
| Food Handling | 2 | 2012 | 35 | 0.150 |
Why?
|
| Oxidative Stress | 2 | 2017 | 990 | 0.150 |
Why?
|
| Reproducibility of Results | 2 | 2023 | 1058 | 0.140 |
Why?
|
| Chemistry, Physical | 2 | 2008 | 50 | 0.140 |
Why?
|
| Dosage Forms | 1 | 2017 | 4 | 0.140 |
Why?
|
| Chemical Phenomena | 2 | 2008 | 56 | 0.140 |
Why?
|
| Static Electricity | 2 | 2008 | 85 | 0.140 |
Why?
|
| Limit of Detection | 1 | 2017 | 82 | 0.130 |
Why?
|
| Growth and Development | 1 | 2017 | 9 | 0.130 |
Why?
|
| Nylons | 1 | 2016 | 2 | 0.130 |
Why?
|
| Cotton Fiber | 1 | 2016 | 5 | 0.130 |
Why?
|
| Drug Combinations | 1 | 2017 | 102 | 0.130 |
Why?
|
| Models, Chemical | 2 | 2008 | 205 | 0.130 |
Why?
|
| Drug Contamination | 1 | 2016 | 11 | 0.130 |
Why?
|
| Larva | 1 | 2017 | 131 | 0.120 |
Why?
|
| Predictive Value of Tests | 2 | 2008 | 438 | 0.120 |
Why?
|
| Evaluation Studies as Topic | 1 | 2016 | 62 | 0.120 |
Why?
|
| Linear Models | 1 | 2017 | 311 | 0.120 |
Why?
|
| Female | 4 | 2025 | 24018 | 0.120 |
Why?
|
| Skin | 1 | 2016 | 185 | 0.120 |
Why?
|
| Chrysenes | 1 | 2015 | 5 | 0.110 |
Why?
|
| Mass Spectrometry | 1 | 2016 | 279 | 0.110 |
Why?
|
| Fluorenes | 1 | 2015 | 26 | 0.110 |
Why?
|
| Texas | 2 | 2008 | 428 | 0.110 |
Why?
|
| Fluorescence | 1 | 2015 | 113 | 0.110 |
Why?
|
| Distillation | 1 | 2014 | 3 | 0.110 |
Why?
|
| Reactive Oxygen Species | 1 | 2017 | 518 | 0.110 |
Why?
|
| Benzo(a)pyrene | 1 | 2015 | 128 | 0.100 |
Why?
|
| Myrtaceae | 1 | 2012 | 1 | 0.100 |
Why?
|
| Thymol | 1 | 2012 | 2 | 0.100 |
Why?
|
| Lamiaceae | 1 | 2012 | 3 | 0.100 |
Why?
|
| Picrates | 1 | 2012 | 7 | 0.100 |
Why?
|
| Eugenol | 1 | 2012 | 6 | 0.100 |
Why?
|
| Biphenyl Compounds | 1 | 2012 | 52 | 0.090 |
Why?
|
| Eye Infections, Fungal | 1 | 2010 | 2 | 0.090 |
Why?
|
| United States | 2 | 2015 | 5072 | 0.090 |
Why?
|
| Keratitis | 1 | 2010 | 2 | 0.080 |
Why?
|
| Amphotericin B | 1 | 2010 | 25 | 0.080 |
Why?
|
| Dietary Supplements | 1 | 2012 | 208 | 0.080 |
Why?
|
| Fluconazole | 1 | 2010 | 41 | 0.080 |
Why?
|
| Microwaves | 2 | 2014 | 27 | 0.080 |
Why?
|
| Time Factors | 2 | 2025 | 1848 | 0.080 |
Why?
|
| Noxae | 1 | 2008 | 1 | 0.080 |
Why?
|
| Hydrocarbons, Brominated | 1 | 2008 | 4 | 0.080 |
Why?
|
| United States Environmental Protection Agency | 1 | 2008 | 6 | 0.070 |
Why?
|
| United States Food and Drug Administration | 1 | 2008 | 28 | 0.070 |
Why?
|
| Cell Line, Tumor | 2 | 2025 | 2598 | 0.070 |
Why?
|
| Antineoplastic Agents, Phytogenic | 1 | 2008 | 134 | 0.060 |
Why?
|
| Chromatography, Gas | 1 | 2006 | 16 | 0.060 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2011 | 1737 | 0.060 |
Why?
|
| HCT116 Cells | 1 | 2025 | 40 | 0.060 |
Why?
|
| Exercise Tolerance | 1 | 2025 | 22 | 0.060 |
Why?
|
| Hep G2 Cells | 1 | 2025 | 62 | 0.060 |
Why?
|
| Fumarates | 1 | 2025 | 11 | 0.060 |
Why?
|
| Middle Aged | 3 | 2025 | 11819 | 0.060 |
Why?
|
| Seizures | 1 | 2025 | 79 | 0.060 |
Why?
|
| Recovery of Function | 1 | 2025 | 107 | 0.060 |
Why?
|
| Cyclin-Dependent Kinase 2 | 1 | 2024 | 32 | 0.060 |
Why?
|
| Magnetic Resonance Spectroscopy | 1 | 2006 | 300 | 0.060 |
Why?
|
| Solvents | 1 | 2005 | 109 | 0.050 |
Why?
|
| Observer Variation | 1 | 2023 | 58 | 0.050 |
Why?
|
| Randomized Controlled Trials as Topic | 1 | 2025 | 358 | 0.050 |
Why?
|
| Rats | 1 | 2011 | 3701 | 0.050 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2023 | 577 | 0.040 |
Why?
|
| Male | 2 | 2025 | 22779 | 0.040 |
Why?
|
| Adult | 2 | 2011 | 13458 | 0.030 |
Why?
|
| Aged | 2 | 2025 | 7982 | 0.030 |
Why?
|
| Risk Factors | 1 | 2025 | 3942 | 0.030 |
Why?
|
| Retrospective Studies | 1 | 2023 | 2485 | 0.030 |
Why?
|
| Corneal Ulcer | 1 | 2010 | 1 | 0.020 |
Why?
|
| Conjunctiva | 1 | 2010 | 6 | 0.020 |
Why?
|
| Injections | 1 | 2010 | 40 | 0.020 |
Why?
|
| Ophthalmic Solutions | 1 | 2010 | 18 | 0.020 |
Why?
|
| Candida | 1 | 2010 | 41 | 0.020 |
Why?
|
| Drug Therapy, Combination | 1 | 2010 | 233 | 0.020 |
Why?
|
| Young Adult | 1 | 2010 | 4936 | 0.010 |
Why?
|
| Adolescent | 1 | 2010 | 5950 | 0.010 |
Why?
|